EMA-CO Regimen

Preferred Label : EMA-CO Regimen;

NCIt synonyms : EMA/CO Regimen; Etoposide-Methotrexate-Actinomycin-D-Cyclophosphamide-Oncovin Regimen; Etoposide/Methotrexate/Actinomycin-D/Cyclophosphamide/Vincristine Regimen; Actinomycin/Cyclophosphamide/Etoposide/Methotrexate/Vincristine; Etoposide/Methotrexate/Actinomycin D/Cyclophosphamide/Vincristine Regimen;

NCIt related terms : EMACO; EMA-CO;

NCIt definition : A regimen consisting of etoposide, high-dose methotrexate and dactinomycin (Actinomycin-D), followed by cyclophosphamide and vincristine, used for the treatment of metastatic gestational trophoblastic tumors (GTT).;

Codes from synonyms : 47654;

Details

Origin ID

C67511;

UMLS CUI

C2348364;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
UMLS correspondences (same concept)
- EMA-CO protocol [MeSH concept]
- EMA-CO protocol [MeSH Supplementary Concept]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Dactinomycin [NCIt concept]
- Etoposide [NCIt concept]
- Methotrexate [NCIt concept]
- Vincristine [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database-Regimen [NCIt concept]
regimen_has_accepted_use_for_disease
- Gestational Trophoblastic Tumor [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients